The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
Self-citationMethylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
Issa, J.-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., & Baylin, S. B. (1994) · Nature Genetics · doi:10.1038/ng0894-536 · Cited by 1,191
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer
Li, Q.-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K.-I., Chi, X.-Z., Lee, K.-Y., Nomura, S., Lee, C.-W., Han, S.-B., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00690-6 · Cited by 1,028
Barrett's Esophagus; Development of Dysplasia and Adenocarcinoma
Hameeteman, W., Tytgat, G. N. J., Houthoff, H. J., & van den Tweel, J. G. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80011-3 · Cited by 859
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation
Montgomery, E., Bronner, M. P., Goldblum, J. R., Greenson, J. K., Haber, M. M., Hart, J., Lamps, L. W., Lauwers, G. Y., Lazenby, A. J., Lewin, D. N., et al. (2001) · Human Pathology · doi:10.1053/hupa.2001.23510 · Cited by 823
Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus
Sampliner, R. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04267-3 · Cited by 657
Spechler, S. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp012118 · Cited by 587
Surveillance and survival in Barrett's adenocarcinomas: A population-based study
Corley, D. A., Levin, T. R., Habel, L. A., Weiss, N. S., & Buffler, P. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.31879 · Cited by 506
Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review
Shaheen, N., & Ransohoff, D. F. (2002) · JAMA · doi:10.1001/jama.287.15.1972 · Cited by 482
Evolution of neoplastic cell lineages in Barrett oesophagus
Barrett, M. T., Sanchez, C. A., Prevo, L. J., Wong, D. J., Galipeau, P. C., Paulson, T. G., Rabinovitch, P. S., & Reid, B. J. (1999) · Nature Genetics · doi:10.1038/8816 · Cited by 441
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus
Cameron, A. J., Lomboy, C. T., Pera, M., & Carpenter, H. A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90642-8 · Cited by 420
Peters, J. H., Clark, G. W. B., Ireland, A. P., Chandrasoma, P., Smyrk, T. C., & DeMeester, T. R. (1994) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(94)70178-4 · Cited by 409
Reid, B. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02798-8 · Cited by 365
Galipeau, P. C., Cowan, D. S., Sanchez, C. A., Barrett, M. T., Emond, M. J., Levine, D. S., Rabinovitch, P. S., & Reid, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7081 · Cited by 360
O'Connor, J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00331-7 · Cited by 357
Relevance of DNA methylation in the management of cancer
Esteller, M. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01115-x · Cited by 329
Endoscopic surveillance of Barrett's esophagus. Does it help?
Streitz, J. M., Andrews, C. W., & Ellis, F. H. (1993) · PubMed · Cited by 297
Montgomery, E., Goldblum, J. R., Greenson, J. K., Haber, M. M., Lamps, L. W., Lauwers, G. Y., Lazenby, A. J., Lewin, D. N., Robert, M. E., Washington, K., et al. (2001) · Human Pathology · doi:10.1053/hupa.2001.23511 · Cited by 291
Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.
Miros, M., Kerlin, P., & Walker, N. I. (1991) · Gut · doi:10.1136/gut.32.12.1441 · Cited by 271
Avidan, B. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04259-4 · Cited by 265
Issa, J. P., Vertino, P. M., Boehm, C. D., Newsham, I. F., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11757 · Cited by 253
Endoscopic surveillance of Barrett’s esophagus
Streitz, J. M., Andrews, C. W., & Ellis, F. H. (1993) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)34219-9 · Cited by 252
The rising trend in oesophageal adenocarcinoma and gastric cardia
Powell, J., & McConkey, C. C. (1992) · European Journal of Cancer Prevention · doi:10.1097/00008469-199204000-00008 · Cited by 248
Bani-Hani, K., Martin, I. G., Hardie, L. J., Mapstone, N., Briggs, J. A., Forman, D., & Wild, C. P. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1316 · Cited by 247
Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus
Menke-Pluymers, M. B. E., Hop, W. C. J., Dees, J., van Blankenstein, M., & Tilanus, H. W. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4<1155::aid-cncr2820720404>3.0.co;2-c · Cited by 224
Weston, A. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02414-5 · Cited by 217
Galipeau, P. C., Prevo, L. J., Sanchez, C. A., Longton, G. M., & Reid, B. J. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2087 · Cited by 214
Selectively Advantageous Mutations and Hitchhikers in Neoplasms
Maley, C. C., Galipeau, P. C., Li, X., Sanchez, C. A., Paulson, T. G., & Reid, B. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3249 · Cited by 214
Weston, A. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00661-9 · Cited by 202
Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus
Klump, B., Hsieh, C.-J., Holzmann, K., Gregor, M., & Porschen, R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70016-2 · Cited by 186
Aging, DNA methylation and cancer
Issa, J.-P. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00019-0 · Cited by 185
Bian, Y., Osterheld, M., Fontolliet, C., Bosman, F. T., & Benhattar, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32370 · Cited by 182
Miyamoto, K., Asada, K., Fukutomi, T., Okochi, E., Yagi, Y., Hasegawa, T., Asahara, T., Sügimura, T., & Ushijima, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206146 · Cited by 162
Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands
Bender, C. M., Gonzalgo, M. L., Gonzales, F. A., Nguyen, C. T., Robertson, K. D., & Jones, P. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6690 · Cited by 156
p53 Mutations in Barrett's adenocarcinoma and high-grade dysplasia
Neshat, K., Sanchez, C. A., Galipeau, P. C., Blount, P. L., Levine, D. S., Joslyn, G., & Reid, B. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90415-4 · Cited by 142
Tumor suppressor activity of RUNX3
Bae, S., & Choi, J.-K. (2004) · Oncogene · doi:10.1038/sj.onc.1207286 · Cited by 134
Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer
Li, Q.-L., Kim, H.-R., Kim, W., Choi, J.-K., Lee, Y. H., Kim, H.-M., Li, L. S., Kim, H., Chang, J., Ito, Y., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.079 · Cited by 133
Biomarkers of Esophageal Adenocarcinoma and Barrett’s Esophagus
McManus, D. T., Olaru, A., & Meltzer, S. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2438 · Cited by 125
Self-citationGopal, D. V., Lieberman, D. A., Magaret, N. D., et al. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1024715824149 · Cited by 113
Soldes, O. S., Kuick, R., Thompson, I. A., Hughes, S. J., Orringer, M., Iannettoni, M. D., Hanash, S., & Dg, B. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690094 · Cited by 109
Waki, T., Tamura, G., Sato, M., Terashima, M., Nishizuka, S., & Motoyama, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01447.x · Cited by 96
Epigenetics in Carcinogenesis and Cancer Prevention
Jones, P. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05976.x · Cited by 95
Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers
Suzuki, H., Zhou, X., Yin, J., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.10.1883 · Cited by 79
Self-citationHemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma
Xiao, W., & Liu, W.-W. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i3.376 · Cited by 73
Mori, Y., Yin, J., Sato, F., Sterian, A., Simms, L. A., Selaru, F. M., Schulmann, K., Xu, Y. H., Olaru, A., Wang, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3508 · Cited by 70
Self-citationFrequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma
Oshimo, Y., Oue, N., Mitani, Y., Nakayama, H., Kitadai, Y., Yoshida, K., Chayama, K., & Yasui, W. (2004) · International Journal of Cancer · doi:10.1002/ijc.20090 · Cited by 66
Biallelic inactivation of the RIZ1 gene in human gastric cancer
Tokumaru, Y., Nomoto, S., Jerónimo, C., Henrique, R., Harden, S., Trink, B., & Sidransky, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206403 · Cited by 58
Carling, T., Du, Y., Fang, W., Correa, P., & Huang, S. (2003) · Surgery · doi:10.1016/s0039-6060(03)00422-7 · Cited by 57
Cited by
Inflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Spechler, S. J., Sharma, P., Souza, R. F., Inadomi, J. M., & Shaheen, N. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.031 · Cited by 1,060
Inflammation: Gearing the journey to cancer
KUNDU, J., & SURH, Y. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.002 · Cited by 803
Ross-Innes, C. S., Becq, J., Warren, A., Cheetham, R. K., Northen, H., O'Donovan, M., Malhotra, S., di Pietro, M., Ivakhno, S., He, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3357 · Cited by 297
Kelloff, G. J., Lippman, S. M., Dannenberg, A. J., Sigman, C. C., Pearce, H. L., Reid, B. J., Szabo, E., Jordan, V. C., Spitz, M. R., Mills, G. B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1104 · Cited by 270
Metadata
- Authors
- Schulmann, K., Sterian, A., Berki, A., Yin, J., Sato, F., Xu, Y., Olaru, A., Wang, S., Mori, Y., Deacu, E., Hamilton, J., Kan, T., Krasna, M. J., Beer, D. G., Pepe, M. S., Abraham, J. M., Feng, Z., Schmiegel, W., Greenwald, B. D., & Meltzer, S. J.
- Venue
- Oncogene
- Published
- 2005-04-11
- Volume
- 24
- Issue
- 25
- Pages
- 4138-4148
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2140525070
- Cited by
- 259
- References
- 54
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.